Axsome Therapeutics, Inc. (AXSM)

Nasdaq · Healthcare · Biotechnology
$129.36-4.66%As of 2026-11-22 · USD
Last session low $128.24Last session high $135.09
52-week low $123.0052-week high $260.19
Market cap
$6.80B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)36.4In the neutral range (30 to 70)
MACD (12, 26, 9)-7.38Above its signal line (-8.66); histogram 1.28
Bollinger %B (20, 2)1%Inside the bands (129.10 to 148.87)
SMA 20138.98Price is 6.9% below
SMA 50163.85Price is 21.0% below
SMA 200195.81Price is 33.9% below
ATR (20)5.32% of priceAverage true range per day
52-week position5%In the lower part of the 123.00 to 260.19 range

About Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Insider filings, 90 daysNo purchases and 1 sale (about $2.1M).
Latest fiscal yearEnded 2025-12-31: revenue of $638.50M and an operating margin of -26.5%.

More in Biotechnology